Patent details
EP2278960 Title: DOSING REGIMEN FOR A SELECTIVE SIP1 RECEPTOR AGONIST
Basic Information
- Publication number:
- EP2278960
- PCT Application Number:
- IB2009051030
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP097217038
- PCT Publication Number:
- WO2009115954
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- DOSING REGIMEN FOR A SELECTIVE SIP1 RECEPTOR AGONIST
- French Title of Invention:
- RÉGIME DE DOSAGE POUR UN AGONISTE SÉLECTIF DU RÉCEPTEUR S1P1
- German Title of Invention:
- DOSIERSCHEMA FÜR EINEN SELEKTIVEN SIP1-REZEPTOR-AGONISTEN
- SPC Number:
Dates
- Filing date:
- 12/03/2009
- Grant date:
- 30/11/2016
- EP Publication Date:
- 02/02/2011
- PCT Publication Date:
- 24/09/2009
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 02/02/2011
- EP B1 Publication Date:
- 30/11/2016
- EP B2 Publication Date:
- 13/11/2019
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 12/03/2029
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/07/2025
- Name:
- Laboratoires Juvise Pharmaceuticals
- Address:
- 149 boulevard Bataille de Stalingrad, 69100 Villeurbanne, France (FR)
History of Owners
- From:
- 06/11/2019
- To:
- 21/07/2025
- Name:
- Actelion Pharmaceuticals Ltd.
- Address:
- Gewerbestrasse 16, 4123 Allschwil, Switzerland (CH)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 28/12/2016
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- DINGEMANSE, Jasper
- Address:
- Switzerland (CH)
2
- Name:
- NAYLER, Oliver
- Address:
- Switzerland (CH)
3
- Name:
- BROSSARD, Patrick
- Address:
- Switzerland (CH)
4
- Name:
- STEINER, Beat
- Address:
- Switzerland (CH)
5
- Name:
- SCHERZ, Michael
- Address:
- Switzerland (CH)
Priority
- Priority Number:
- PCT/IB2008/050995
- Priority Date:
- 17/03/2008
- Priority Country:
- World Intellectual Property Office (WIPO) (WO)
Classification
- IPC classification:
- A61K 31/00; A61K 31/426; A61P 9/06;
Publication
Bulletin
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2025/09
- Publication date:
- 05/08/2025
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
European Patent Bulletin
1
- Issue number:
- 201740
- Publication date:
- 04/10/2017
- Description:
- Opposition procedure started
2
- Issue number:
- 201946
- Publication date:
- 13/11/2019
- Description:
- Patent maintained (B2 publication)
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20250000249A
- Date Registered:
- 21/07/2025
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- Dennemeyer & Associates S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- Laboratoires Juvise Pharmaceuticals
- Address:
- 149 boulevard Bataille de Stalingrad, 69100 Villeurbanne, France (FR)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 31/03/2027
- Annual Fee Number:
- 19
- Annual Fee Amount:
- 281 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 19/03/2026
- Last Annual Fee Paid Number:
- 18
- Last Annual Fee Paid Amount:
- 262 Euro
- Payer:
- DENNEMEYER & CO
| Filing date | Document type | Number of pages |
|---|---|---|
| 21/07/2025 | Request For Change | 35 |
| 30/07/2025 | Outgoing Correspondence | 1 |